| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/10/2000 | WO2000045856A2 Novel methods of imaging and treatment with targeted compositions |
| 08/10/2000 | WO2000045855A2 Diagnostic imaging of lymph structures |
| 08/10/2000 | WO2000045854A2 Preparations for time-limited marking of biopsy sites |
| 08/10/2000 | WO2000016099A9 Recombinant reduced valency carbohydrate binding ligands |
| 08/10/2000 | CA2362200A1 Novel methods of imaging and treatment with targeted compositions |
| 08/10/2000 | CA2360745A1 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 08/09/2000 | EP1026245A1 Antigen protein and nucleic acid coding for said protein |
| 08/09/2000 | EP1026171A1 Polymer modification |
| 08/09/2000 | EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens |
| 08/09/2000 | EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 08/09/2000 | EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 08/09/2000 | EP1024838A1 Stable radioiodine conjugates and methods for their synthesis |
| 08/09/2000 | EP1024837A1 Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug |
| 08/09/2000 | EP0825851A4 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 08/09/2000 | CN1262619A Process for preparing reactive pharmaceutical product for detection of gastrointestinal disorder caused by bacteria |
| 08/08/2000 | US6099832 Transplants for myocardial scars |
| 08/08/2000 | US6099824 Use as contrast agents in magnetic resonance imaging |
| 08/08/2000 | CA2097695C Biological stain composition, method of preparation and method of use for delineation of epithelial cancer |
| 08/03/2000 | WO2000045167A2 Non-invasive method for detecting target rna |
| 08/03/2000 | WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc |
| 08/03/2000 | WO2000044348A2 Materials and methods for making improved micelle compositions |
| 08/03/2000 | WO1998017782A8 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| 08/03/2000 | CA2360997A1 Non-invasive method for detecting target rna |
| 08/03/2000 | CA2359317A1 Method of treating restenosis by antisense targeting of c-myc |
| 08/02/2000 | EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 08/02/2000 | EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove |
| 08/02/2000 | EP0630407B1 Anti-viral fusion peptides |
| 08/02/2000 | CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/02/2000 | CN1261810A Method of screening compounds useful for prevention of infection or pathogenicity |
| 08/02/2000 | CN1261809A Method for enhancing echogenicity and decreasing attenuation of microencapsulated gases |
| 08/02/2000 | CN1261791A Targeted liposomal constructs for diagnostic and therapeutic uses |
| 08/01/2000 | US6096734 Photosensitizers for sensitizing cells |
| 08/01/2000 | US6096551 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | US6096331 Methods and compositions useful for administration of chemotherapeutic agents |
| 08/01/2000 | US6096290 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 08/01/2000 | US6096289 Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy |
| 08/01/2000 | US6095134 Methods and apparatus for fine particle formation |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/27/2000 | WO2000043550A2 Method and apparatus for measuring factors in mammary fluids |
| 07/27/2000 | WO2000043401A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | WO2000043004A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 07/27/2000 | WO2000021577A3 Compositions |
| 07/27/2000 | DE19902387A1 Assay for nitric oxide synthase activity in vivo comprises rapid infusion of arginine labeled with at least two stable isotopes |
| 07/27/2000 | CA2361115A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 07/27/2000 | CA2361064A1 Boron steroid mimics and pharmaceutical compositions |
| 07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 07/26/2000 | EP1021203A2 Delivery system |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP0643583B1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 07/26/2000 | CN1054776C B-ultrasonic quick-developing agent for examination of gastrointestinal tract |
| 07/25/2000 | US6093399 Specific blood coagulation exemplified by in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody |
| 07/25/2000 | US6093382 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 07/20/2000 | WO2000042010A1 Contrast media for angiography |
| 07/20/2000 | WO2000041514A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 07/20/2000 | WO2000018949A3 Delivery of phosphoinositide polyphosphates into cells |
| 07/20/2000 | WO2000013590A3 System and method for radiographic imaging of tissue |
| 07/20/2000 | WO2000012140A8 Method for labeling biopolymers using isotopes |
| 07/20/2000 | CA2360560A1 Contrast media for angiography |
| 07/19/2000 | EP1019423A2 Method for producing a pentopyranosyl nucleoside |
| 07/19/2000 | EP1019413A1 Metallation of macrocycles with 2,4-dicarbonyl-metal complexes |
| 07/19/2000 | EP1019094A2 Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
| 07/19/2000 | EP1019093A1 Ultrasound bubble recognition imaging |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019085A1 Non-anaphylactic forms of allergens and their use |
| 07/19/2000 | EP1019043A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
| 07/19/2000 | EP1019023A1 Stabilized preparations for use in nebulizers |
| 07/19/2000 | EP1019022A1 Perforated microparticles and methods of use |
| 07/19/2000 | EP1019021A1 Stabilized preparations for use in metered dose inhalers |
| 07/19/2000 | EP1019020A1 Stabilized bioactive preparations and methods of use |
| 07/19/2000 | EP0772628B1 Peptide derived radionuclide chelators |
| 07/19/2000 | CN1054545C Contrast media and use thereof |
| 07/18/2000 | US6091974 Implantable capsule for enhancing cell electric signals |
| 07/18/2000 | US6091000 SCID mouse engrafted with human synovium tissue |
| 07/18/2000 | US6090800 Reaction product containing dexamethasone |
| 07/18/2000 | US6090793 Non-mitogenic substance, its preparation and use |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090408 Crosslinked lipids; in situ detection |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040274A1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040082A1 Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents |
| 07/13/2000 | WO2000021576A3 Method for viewing tumor tissue located within a body cavity |
| 07/13/2000 | CA2355865A1 Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents |
| 07/12/2000 | EP1017980A2 Methods of the identification of pharmaceutically active compounds |
| 07/12/2000 | EP1017704A2 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside |
| 07/12/2000 | EP1017703A2 Pentopyranosyl nucleoside, and production and use of the same |
| 07/12/2000 | EP1017684A1 Contrasting agent for infarct and necrosis imaging |
| 07/12/2000 | EP1017425A1 Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator |
| 07/12/2000 | EP1017424A1 Lipophilic metal complexes for necrosis and infarct imaging |
| 07/12/2000 | EP1017422A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 07/12/2000 | EP1017421A1 Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue |
| 07/12/2000 | EP0896655A4 High volume hyperpolarizer for spin-polarized noble gas |
| 07/12/2000 | EP0808125A4 Calcium/oxyanion-containing particles for use in medical diagnostic imaging |
| 07/12/2000 | CN1259959A GnRh antagonists being modified in positions 5 and 6 |
| 07/12/2000 | CN1054373C Full fluoralkyl-substituted bezoylguanidine prepn. pharmaceutical use of same and pharmaceutical containing same |
| 07/11/2000 | US6088613 Method of magnetic resonance focused surgical and therapeutic ultrasound |
| 07/11/2000 | US6087556 Transgenic animals capable of replicating hepatitis viruses and mimicking chronic hepatitis infection in humans |
| 07/11/2000 | US6087486 Dna molecules encoding rip-1 protein which binds to the human immunodeficiency virus viral protein r; viricides and prophylactic agents |
| 07/11/2000 | US6087483 DNA coding an inositol 1,4,5,-triphosphate binding protein |